Evidence map›Paper›PMID 40232662›Full record

ArticleInfection2025

Identifying patients at high risk for antibiotic treatment following hospital admission: a predictive score to improve antimicrobial stewardship measures.

Moritz Beck, Carolin Koll, Uga Dumpis, Christian G Giske, Siri Göpel, Silje Bakken Jørgensen, Johanna Kessel, Lars Kaare Kleppe, Dorthea Hagen Oma, Noa Eliakim Raz and 8 more

Registry-linked trialAbstract read
In one paragraph

Article in Infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03765528 (Impact of Prescription Quality, Infection Control and Antimicrobial Stewardship on Gut Microbiota Domination by Healthcare-Associated Pathogens), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03765528 unknown statusnot on this map

Impact of Prescription Quality, Infection Control and Antimicrobial Stewardship on Gut Microbiota Domination by Healthcare-Associated Pathogens

TypeobservationalSponsorUniversity Hospital of CologneRan2019 to 2022Enrolled1,500ConditionsPatients at High Risk of Antibacterial Treatment Upon Admission
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Moritz BeckDepartment I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.ORCID http://orcid.org/0009-0001-1969-3033
Carolin KollDepartment I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.ORCID http://orcid.org/0000-0001-7940-3264
Uga DumpisFaculty of Medicine, University of Latvia, Riga, Latvia.ORCID http://orcid.org/0000-0001-6778-9411
Christian G GiskeDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-4327-6122
Siri GöpelDepartment of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-7666-4634
Silje Bakken JørgensenDepartment of Medical Microbiology and Infection Control and Department of Emergency Care, Akershus University Hospital, Lørenskog, Norway.ORCID http://orcid.org/0000-0002-3135-1431
Johanna KesselDepartment II of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt Am Main, Germany.
Lars Kaare KleppeDepartment of Infection Prevention and Control, Stavanger University Hospital, Stavanger, Norway.ORCID http://orcid.org/0009-0000-4466-6187
Dorthea Hagen OmaSection for Patient Safety, Haukeland University Hospital, Bergen, Norway.
Noa Eliakim RazInternal medicine E, Rabin medical center Beilinson campus, Petah-Tikva, Israel.
Makeda SemretInfectious Diseases and Medical Microbiology, Mcgill University Health Centre, Montreal, Canada.ORCID http://orcid.org/0000-0003-3875-4847
Gunnar Skov SimonsenDepartment of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.ORCID http://orcid.org/0000-0003-0043-7045
Maria J G T VehreschildDepartment II of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt Am Main, Germany.ORCID http://orcid.org/0000-0003-0446-3224
Kerstin AlbusDepartment I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.ORCID http://orcid.org/0000-0003-1124-4310
Lena M BiehlDepartment I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.ORCID http://orcid.org/0000-0001-7613-8119
Jörg J VehreschildFaculty of Medicine and University Hospital of Frankfurt, Institute for Digital Medicine and Clinical Data Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0002-5446-7170
Annika Y ClassenDepartment I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. annika.classen@uk-koeln.de.ORCID http://orcid.org/0000-0003-2905-5139
PILGRIM study group

Funding

Joint Programming Initiative on Antimicrobial Resistance 01KI1735
6 · The paper itself

Abstract

purposeIdentifying patients for clinical studies evaluating strategies to reduce unnecessary antibiotic usage in hospitals is challenging. This study aimed to develop a predictive score to identify newly hospitalized patients with high likelihood of receiving antibiotics, thus improving patient inclusion in future studies focusing on antimicrobial stewardship (AMS) programs.

methodsThis retrospective analysis used data from the PILGRIM study (NCT03765528), which included 1,600 patients across ten international sites. Predictive variables for antibiotic treatment during hospitalization were computed, and an additive score model was developed using logistic regression and 10-fold cross-validation. The PILGRIM score was validated in an independent cohort (validation cohort), with performance metrics assessed.

resultsData from 1,258 patients was included. In the development cohort 52.8% (n = 445) and in the validation cohort 42.4% (n = 134) of patients received antibiotics. Key predictors included hematologic malignancies, immunosuppressive medication, and past hospitalization. The logistic regression model demonstrated an area under the curve of 0.74 in the validation. The final additive score incorporated these predictors plus "planned elective surgery" achieving a specificity of 92%, a positive predictive value of 78%, a sensitivity of 41%, and a negative predictive value (NPV) of 69%in validation set.

conclusionThe PILGRIM score effectively identifies newly hospitalized patients likely to receive antibiotics, demonstrating high specificity and PPV. Its application can improve future AMS programs and trial recruitment by facilitating targeted inclusion of patients, especially in the hematological and oncological setting. Further -external and prospective- validation is needed to broaden the model's applicability.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipAdultAgedAged, 80 and overFemaleHospitalizationHumansLogistic ModelsMaleMiddle AgedObservational Studies as TopicRetrospective StudiesAnti-Bacterial AgentsAntibiotic treatmentAntimicrobial stewardshipClinical trialPrediction score

Identifiers

PMID40232662
PMCPMC12460503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.